|
|
| Home > Treating Your Condition > Pediatric Crohn's Disease > REMICADE and Pediatric Crohn's Disease > Pediatric Crohn's Disease Clinical Study |
|
Please read the Medication Guide for REMICADE and discuss with your doctor.
Pediatric Crohn’s Disease Clinical StudyREMICADE is for children (ages 6-17) with moderate to severe Crohn's disease who haven't responded well to other therapies. REMICADE has been approved for the treatment of pediatric Crohn’s disease, based on the REACH clinical study. To read more about this clinical study and its results, please visit the following resource. |